BCA
AXDX

Bray Capital Advisors’s Accelerate Diagnostics AXDX Stock Holding History

Bray Capital Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100
Closed -$16K – 141
2015
Q3 		$16K Hold
100
– – 0.01% 286
2015
Q2 		$26K Buy
+100
New +$23.9K 0.01% 267

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
MGM
Miura Global Management New York $43.8M AUM 53.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bray Capital Advisors's AXDX Position: Q4 2015 in Review

Bray Capital Advisors sold out of Accelerate Diagnostics (AXDX) in Q4 2015, closing a stake of 100 shares — an estimated $16K sold.

Bray Capital Advisors first reported a position in AXDX in Q2 2015 and held it in 2 quarters. The position peaked at $26K in Q2 2015. 97 funds tracked by Wall St. Rank hold AXDX as of Q4 2015.

  • Bray Capital Advisors reported no remaining Accelerate Diagnostics position as of Q4 2015 after selling out during the quarter.
  • Bray Capital Advisors sold 100 Accelerate Diagnostics shares in Q4 2015, an estimated $16K.
  • Bray Capital Advisors first reported a position in Accelerate Diagnostics in Q2 2015 and held it in 2 quarters.
  • Bray Capital Advisors's Accelerate Diagnostics position peaked at $26K in Q2 2015.
  • 97 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2015.

Based on Bray Capital Advisors's 13F filing for Q4 2015, filed 1 Feb 2016.